Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fussel-18 Inhibitors

Fussel-18 inhibitors represent a class of chemical compounds characterized by their ability to selectively bind to and modulate the activity of the Fussel-18 protein, a molecule that plays a pivotal role in certain biochemical pathways within cells. The name "Fussel-18" itself comes from a nomenclature that typically relates to the sequence or discovery of the protein within a particular scientific investigation or its characteristic structure or function. These inhibitors are often highly specialized molecules, designed through an intricate process of medicinal chemistry, to achieve a high degree of specificity towards the Fussel-18 protein. This selectivity is crucial, as it ensures that the interaction with the target protein does not inadvertently affect other proteins with similar structures or functions, which could lead to undesired effects.

The chemical structure of Fussel-18 inhibitors is usually complex, featuring a core scaffold that interacts with the active site or a specific binding region on the Fussel-18 protein. Surrounding this core, there may be a variety of chemical groups-such as rings, chains, or heteroatoms-that enhance the inhibitor's affinity for the protein or its overall stability within biological systems. The development of these inhibitors often requires a deep understanding of the structure and dynamics of the Fussel-18 protein, obtained through techniques like X-ray crystallography or NMR spectroscopy. These structural insights allow chemists to design and synthesize Fussel-18 inhibitors that fit into the protein's architecture much like a key fits into a lock. The interaction between the inhibitor and the protein is typically governed by a combination of hydrogen bonds, hydrophobic interactions, and van der Waals forces, which together contribute to the potency and selectivity of the inhibitor.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

Inhibits ALK5, ALK4, and ALK7, which are TGF-β type I receptors, and can prevent SMAD2/3 activation, potentially inhibiting Fussel-18 activity downstream.

LY2157299

700874-72-2sc-391123
sc-391123A
5 mg
10 mg
$213.00
$359.00
3
(1)

Selectively inhibits TGF-β receptors I and II, possibly reducing SMAD2/3 phosphorylation affecting Fussel-18 activity.

LY2109761

700874-71-1sc-396262
sc-396262A
1 mg
5 mg
$89.00
$275.00
9
(1)

Inhibits TGF-β receptor I, which may decrease SMAD2/3-mediated transcription that could involve Fussel-18.

ALK5 Inhibitor II

446859-33-2sc-221234
sc-221234A
sc-221234B
sc-221234C
sc-221234D
sc-221234E
sc-221234F
1 mg
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$77.00
$153.00
$219.00
$663.00
$1248.00
$4382.00
$7850.00
8
(1)

Inhibits ALK5, and can thereby block TGF-β-induced SMAD2/3 phosphorylation, potentially affecting Fussel-18's function.

A 83-01

909910-43-6sc-203791
sc-203791A
10 mg
50 mg
$202.00
$811.00
16
(1)

Inhibits ALK5, ALK4, and ALK7, and can block SMAD2/3 phosphorylation, which may reduce Fussel-18 activity.

TGF-β RI Kinase Inhibitor V

627536-09-8sc-203294
2 mg
$88.00
3
(1)

TGF-βRI kinase inhibitor that could inhibit SMAD2/3 activation and thus indirectly reduce Fussel-18 activity.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Inhibits TGF-β type I receptor ALK5, potentially diminishing SMAD2/3 phosphorylation and affecting Fussel-18.

Pirfenidone

53179-13-8sc-203663
sc-203663A
10 mg
50 mg
$102.00
$416.00
6
(1)

Has anti-fibrotic properties that include modulation of TGF-β activity, possibly affecting Fussel-18 indirectly.

Tranilast

53902-12-8sc-200389
sc-200389A
sc-200389B
sc-200389C
10 mg
50 mg
1 g
5 g
$31.00
$103.00
$283.00
$978.00
2
(1)

Inhibits the release of TGF-β from cells and could indirectly inhibit Fussel-18's function in the pathway.

Halofuginone

55837-20-2sc-507290
100 mg
$1775.00
(0)

Inhibits Smad3 phosphorylation, which can lead to an inhibition of Fussel-18's activity if it is downstream of Smad3.